On this page
The editorial assessment
Paying for an evaluation does not purchase a peptide. Is this appointment for assessment only, what tests are proposed, and what current access pathway could apply if treatment is considered?
- Published payment basis
- $450 new-patient consultation; testing and treatment separate
- Preparation record
- Evaluation first; a current BPC prescription is not established by a booking
- Care process
- History, examination and possible imaging/labs described
- Access setting
- Beverly Hills medical evaluation
What is documented
- History, examination and possible imaging/labs described
- Paying for an evaluation does not purchase a peptide
What needs an answer
- The clinic presents BPC-157 as a consultation topic and separates the consultation, tests and any subsequent treatment.
- Is this appointment for assessment only, what tests are proposed, and what current access pathway could apply if treatment is considered?
A consultation record rather than a medication quote
The documented $450 fee is for a new-patient evaluation. Potential imaging, laboratory testing and treatment sit outside it. This distinction prevents the appointment price from being misclassified as a BPC package. In the cost planner, a future pharmacy expense remains unknown rather than zero; the assessment may produce a different treatment recommendation altogether.
The unresolved term
Is this appointment for assessment only, what tests are proposed, and what current access pathway could apply if treatment is considered?
A contrasting service record
The Elevate Health service review documents another purchasing structure: the consultation is required and the menu lists BPC-157 separately; the wording does not justify silently treating either figure as the entire starting bill. That distinction changes which components belong in a like-for-like comparison.
On the record
The documents supporting this report.
- My Concierge MD official BPC-157 service or pricing recordCompany website